Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States.
Graduate School of Public Health, University of Pittsburgh.
Int J Neuropsychopharmacol. 2022 Jan 12;25(1):36-45. doi: 10.1093/ijnp/pyab060.
The serotonin 1A (5-HT1A) receptor has been implicated in depression and suicidal behavior. Lower resting cortisol levels are associated with higher 5-HT1A receptor binding, and both differentiate suicide attempters with depression. However, it is not clear whether 5-HT1A receptor binding and cortisol responses to stress are related to familial risk and resilience for suicidal behavior.
[11C]CUMI-101 positron emission tomography imaging to quantify regional brain 5-HT1A receptor binding was conducted in individuals considered to be at high risk for mood disorder or suicidal behavior on the basis of having a first- or second-degree relative(s) with an early onset mood disorder and history of suicidal behavior. These high-risk individuals were subdivided into the following groups: high risk resilient having no mood disorder or suicidal behavior (n = 29); high risk with mood disorder and no suicidal behavior history (n = 31); and high risk with mood disorder and suicidal behavior (n = 25). Groups were compared with healthy volunteers without a family history of mood disorder or suicidal behavior (n = 34). Participants underwent the Trier Social Stress Task (TSST). All participants were free from psychotropic medications at the time of the TSST and PET scanning.
We observed no group differences in 5-HT1A receptor binding considering all regions simultaneously, nor did we observe heterogeneity of the effect of group across regions. These results were similar across outcome measures (BPND for all participants and BPp in a subset of the sample) and definitions of regions of interest (ROIs; standard or serotonin system-specific ROIs). We also found no group differences on TSST outcomes. Within the high risk with mood disorder and suicidal behavior group, lower BPp binding (β = -0.084, SE = 0.038, P = .048) and higher cortisol reactivity to stress (β = 9.25, 95% CI [3.27,15.23], P = .004) were associated with higher lethality attempts. There were no significant relationships between 5-HT1A binding and cortisol outcomes.
5-HT1A receptor binding in ROIs was not linked to familial risk or resilience protecting against suicidal behavior or mood disorder although it may be related to lethality of suicide attempt. Future studies are needed to better understand the biological mechanisms implicated in familial risk for suicidal behavior and how hypothalamic-pituitary-adrenal axis function influences such risk.
血清素 1A(5-HT1A)受体与抑郁和自杀行为有关。静息皮质醇水平较低与 5-HT1A 受体结合较高有关,两者均能区分伴有抑郁的自杀未遂者。然而,目前尚不清楚 5-HT1A 受体结合和皮质醇对压力的反应是否与自杀行为的家族风险和弹性有关。
对认为存在心境障碍或自杀行为高危人群进行 [11C]CUMI-101 正电子发射断层扫描成像,以定量评估大脑 5-HT1A 受体结合情况。这些高危人群的依据是一级或二级亲属(患有早期发病的心境障碍和自杀行为史)患有心境障碍或有自杀行为史。将这些高危人群分为以下几组:无心境障碍或自杀行为史的高风险有弹性组(n=29);无自杀行为史但有心境障碍的高风险组(n=31);有心境障碍和自杀行为的高风险组(n=25)。将这些组与无心境障碍或自杀行为家族史的健康志愿者(n=34)进行比较。参与者接受了特里尔社会压力测试(TSST)。在进行 TSST 和 PET 扫描时,所有参与者均未服用精神药物。
同时考虑所有区域,我们没有观察到 5-HT1A 受体结合的组间差异,也没有观察到组间效应在区域上的异质性。这些结果在不同的结果测量(所有参与者的 BPND 和样本中一部分的 BPp)和感兴趣区域(ROI;标准或血清素系统特异性 ROI)的定义上都是相似的。我们也没有观察到 TSST 结果的组间差异。在有心境障碍和自杀行为的高风险组中,较低的 BPp 结合(β=-0.084,SE=0.038,P=0.048)和皮质醇对压力的更高反应(β=9.25,95%CI[3.27,15.23],P=0.004)与更高的自杀企图致死率有关。5-HT1A 结合与皮质醇结果之间没有显著关系。
尽管 5-HT1A 受体结合可能与自杀企图的致死率有关,但 ROIs 中的 5-HT1A 受体结合与家族风险或对自杀行为或心境障碍的保护无关。需要进一步的研究来更好地了解与自杀行为家族风险相关的生物学机制,以及下丘脑-垂体-肾上腺轴功能如何影响这种风险。